HFD and HFD+ AmEV fed mice. Animals were given NCD or HFD for 10 weeks followed by oral gavaging of 10μg of AmEV/mouse for 2 weeks. The animals were fasted 16h followed by intra-peritoneal injection of 1g/kg glucose. Blood glucose level was measured using a blood glucose kit at indicated time points. All data are presented as the mean ± SEM of 3 experiments performed in triplicates; n=5-7 per group; * indicates p < 0.05, ** indicates p < 0.01. 0.1µg/ml, 1µg/ml, and 10µg/ml. In-vitro permeability was measured using FITC-Dextran assay.
Supplementary Figure S4
(d) Caco2 cells were pre-treated with AMPK specific inhibitor for 30 min, after which cells were treated with LPS or LPS+ AmEV. TEER resistance was measured using volt-ohm meter (Merck Millipore). (e) Caco2 monolayer transwell was pre-incubated with AMPK-specific inhibitor compound C for 30 min, after which cells were treated with LPS (5µg/ml) or LPS (5µg/ml) + AmEV (1µg/ml ) as indicated. 4 hours later the upper chamber of transwell was treated with 1mg/ml of FITC-Dextran and the fluorescence in the lower chamber was measured after 4 hours using fluorescence spectrometer. All data are presented as the mean ± SEM of 3 experiments performed in triplicates; * indicates p < 0.05, ** indicates p < 0.01.
